)
Proteomics International Laboratories (PIQ) investor relations material
Proteomics International Laboratories Investor Presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Commercial launch and product pipeline
Four first-in-class diagnostic tests launching in FY26 across Australia and the USA, targeting diabetic kidney disease, endometriosis, esophageal cancer, and oxidative stress-related muscle damage.
Tests validated in large clinical studies, offering significant advantages over current standards of care and addressing large unmet medical needs.
Consumer-driven strategy focuses on primary care and GP clinics, supported by a digital platform and engagement with key opinion leaders.
Commercial ramp-up underway for PromarkerD and PromarkerEso, with initial sales achieved and further launches planned.
Patented products and attractive margins position the company for licensing agreements and strategic partnerships.
Market strategy and partnerships
Emphasis on building market awareness and adoption through digital and traditional channels, targeting both end users and potential licensing partners.
Reimbursement pricing for PromarkerD in the USA is imminent, with other tests to follow, supporting near-term revenue growth.
Flexible partnering options include non-exclusive and exclusive licensing, with ongoing discussions with global health and diagnostic companies.
Platform and infrastructure enable rapid tech transfer and product launch, enhancing attractiveness for partners.
Industry and government focus on precision medicine creates additional demand for novel diagnostics.
Financial and operational highlights
Market capitalisation of A$67m as of December 2025, with A$12.7m in cash and a recent A$12m capital raise completed.
Quarterly cash receipts of A$1.8m and cash burn of A$1m in Q1 FY26, supported by a revenue-generating bioanalytical services business.
State-of-the-art laboratories and a US CLIA-certified reference lab established, with headquarters in Perth, WA.
Top 40 shareholders hold 41% of shares, with directors holding 11%, indicating strong alignment.
Fully funded to execute launch strategies and drive commercialisation in FY26.
Next Proteomics International Laboratories earnings date
Next Proteomics International Laboratories earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)